Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
-
+
EP07.01 - Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical
- Type: E-Poster
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical
- Presentations: 26
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP07.01-021 - Clinical and Biochemical Profiling of Pleural Mesothelioma Patients Treated With Immunotherapy
Author(s): Mario Occhipinti- Abstract
Loading...
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Presentations: 108
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP08.01-020 - Phase 2 Platform Trial of Anti-TIGIT GSK’859A/EOS-448 + Anti-PD-1 Dostarlimab in Non-small Cell Lung Cancer (NSCLC)
Author(s): David Spigel- Abstract
Loading... -
+
EP08.01-006 - Using Real World data to build effective predictive machine learining models for NSCLC patients treated with immune-based therapy
Author(s): Arsela Prelaj- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Presentations: 171
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP08.02-108 - Osimertinib Long-Term Tolerability in Patients with EGFRm NSCLC Enrolled in the AURA Program or FLAURA Study
Author(s): Marina Chiara Garassino- Abstract
Loading...
-
+
ES02 - Management of Lung Cancer in the Era of COVID-19 I
- Type: Education Session
- Track: Management of Lung Cancer in the Era of COVID-19
- Presentations: 9
- Moderators:Marina Chiara Garassino
- Coordinates: 8/07/2022, 10:45 - 11:45, Hall C2
-
+
ES02.01 - Session Introduction
10:45 - 10:46 | Author(s): Marina Chiara Garassino
- Abstract
Loading... -
+
ES02.02 - Session Introduction
10:46 - 10:47 | Author(s): Christian Grohe
- Abstract
Loading... -
+
ES02.03 - Impact of the COVID-19 Pandemic on Lung Cancer Diagnosis and Screening
10:47 - 10:59 | Author(s): Betty Tong
- Abstract
Loading... -
+
ES02.04 - Impact of the COVID-19 Pandemic on Surgery
10:59 - 11:11 | Author(s): Leanne Ashrafian
- Abstract
Loading... -
+
Session Moderator
10:59 - 11:11 | Author(s): Marina Chiara Garassino
- Abstract
Loading... -
+
Session Moderator
10:59 - 11:11 | Author(s): Christian Grohe
- Abstract
Loading... -
+
ES02.05 - Impact of the COVID-19 Pandemic on Radiotherapy
11:11 - 11:23 | Author(s): Umberto Ricardi
- Abstract
Loading... -
+
ES02.06 - Impact of the COVID-19 Pandemic on Systemic Treatment
11:23 - 11:35 | Author(s): Wilfried Ernst Erich Eberhardt
- Abstract
Loading... -
+
ES02.07 - Live Q&A
11:35 - 11:45
- Abstract
Loading...
-
+
OA03 - Molecular Targeted Treatments
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Presentations: 11
- Moderators:Andrew Ciupek
- Coordinates: 8/07/2022, 14:30 - 15:40, Hall C7
-
+
OA03.05 - Tepotinib in Patients with MET Exon 14 (METex14) Skipping NSCLC: Primary Analysis of the Confirmatory VISION Cohort C
14:52 - 15:02 | Author(s): Michael Thomas
- Abstract
Loading...
-
+
P1.15 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Type: Regular Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Presentations: 12
- Coordinates: 8/07/2022, 17:00 - 19:00, Exhibit Hall - Hall B
-
+
P1.15-02 - Plasma microRNAs Modulation in Advanced NSCLC Patients Receiving Single Agent Immune Checkpoint Inhibitors
Author(s): Claudia Proto- Abstract
Loading...
-
+
P1.16 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Type: Regular Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Presentations: 4
- Coordinates: 8/07/2022, 17:00 - 19:00, Exhibit Hall - Hall B
-
+
P1.16-04 - Phase 3 EVOKE-01 Study of Sacituzumab Govitecan vs Docetaxel in NSCLC After Prior Platinum and Checkpoint Inhibitors
Author(s): Niels Reinmuth- Abstract
Loading...
-
+
OA06 - Impact of COVID-19 on Cancer Management and Protection from Vaccines
- Type: Oral
- Track: Management of Lung Cancer in the Era of COVID-19
- Presentations: 11
- Moderators:Marina Chiara Garassino
- Coordinates: 8/08/2022, 11:00 - 12:10, Lehar 1
-
+
OA06.01 - Session Introduction
11:00 - 11:01 | Author(s): Marina Chiara Garassino
- Abstract
Loading... -
+
OA06.02 - Session Introduction
11:01 - 11:02 | Author(s): Christian Grohe
- Abstract
Loading... -
+
OA06.03 - Serological Response to SARS-CoV-2 Vaccination in Patients Lung Cancer: A Mount Sinai-Led Prospective Matched Controlled Study
11:02 - 11:12 | Author(s): Philip C Mack
- Abstract
Loading... -
+
OA06.04 - Immune Response after SARS-CoV-2 Vaccination in Lung Cancer Patients. Update of the Covid Lung Vaccine Cohort
11:12 - 11:22 | Author(s): Ainhoa Hernandez
- Abstract
Loading... -
+
OA06.05 - Impact of COVID-19 Pandemic on Proportion and Treatment Patterns for Stage I Non-small Cell Lung Cancer in the Netherlands
11:22 - 11:32 | Author(s): Nienke Wolfhagen
- Abstract
Loading... -
+
OA06.06 - Impact of Systemic Anti-cancer Treatments on Outcomes of COVID-19 in Patients with Thoracic Cancers: CCC19 Registry Analysis
11:32 - 11:42 | Author(s): Amit Kulkarni
- Abstract
Loading... -
+
OA06.07 - Stereotactic Ablative Radiotherapy Before Resection to AvoId Delay for Early-Stage LunG Cancer or OligomEts
11:42 - 11:52 | Author(s): Biniam Kidane
- Abstract
Loading... -
+
Session Moderator
11:42 - 11:52 | Author(s): Marina Chiara Garassino
- Abstract
Loading... -
+
Session Moderator
11:42 - 11:52 | Author(s): Christian Grohe
- Abstract
Loading... -
+
OA06.08 - Discussant
11:52 - 12:02 | Author(s): Marina Chiara Garassino
- Abstract
Loading... -
+
OA06.09 - Live Q&A
12:02 - 12:10
- Abstract
Loading...
-
+
MA10 - Updates in Thymoma
- Type: Mini Oral
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
- Presentations: 13
- Moderators:Noboru Yamamoto
- Coordinates: 8/08/2022, 14:45 - 15:45, Hall C8
-
+
MA10.07 - Phase II Trial of Sunitinib in Patients with Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines - STYLE Trial (NCT03449173)
15:12 - 15:17 | Author(s): Claudia Proto
- Abstract
Loading...
-
+
OA15 - Patient Selection in Advanced NSCLC Immunotherapy
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Presentations: 10
- Moderators:Pilar Garrido
- Coordinates: 8/09/2022, 14:30 - 15:30, Hall C7
-
+
OA15.06 - Pooled Analysis of Outcomes With Second-Course Pembrolizumab Across 5 Phase 3 Studies of Non-Small-Cell Lung Cancer
15:02 - 15:12 | Author(s): Delvys Rodriguez-Abreu
- Abstract
Loading...
